AbCellera Results Presentation Deck

Q2 2023 BUSINESS UPDATE COPYRIGHT © ABCELLERA 5 AbCellera secures ~$220M in non-dilutive funding to accelerate execution of strategy and bring programs into clinic with high capital efficiency. Lab & Office Construction ~$220M Stronger engine. Allows us to offer highly differentiated end-to-end capabilities to select partners. Discovery & Pre-clinical Development ~$190M Clinical Studies ~$100M Enhanced portfolio. Through the advancement of multiple wholly-owned pre-partnered programs from initiation all the way to Phase 1 clinical trials. Total Project Investments ~$520M

View entire presentation